Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -96,207 | -88,853 | -90,210 | -60,345 | -50,158 |
| Depreciation Amortization | 443 | -1,194 | 881 | 1,113 | 1,391 |
| Income taxes - deferred | 511 | 23 | 141 | 392 | 219 |
| Accounts payable and accrued liabilities | -512 | -367 | 1,149 | -722 | 1,727 |
| Other Working Capital | -321 | 4,381 | 1,475 | -1,037 | -1,425 |
| Other Operating Activity | 13,910 | 15,994 | 19,174 | 11,490 | 6,419 |
| Operating Cash Flow | $-82,176 | $-70,016 | $-67,390 | $-49,109 | $-41,827 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -298,043 | -12,368 | -37,935 | -21,997 | -119,356 |
| PPE Investments | N/A | -42 | -52 | -275 | -340 |
| Investing Cash Flow | $-298,043 | $-12,410 | $-37,987 | $-22,272 | $-119,696 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 149,080 |
| Debt Repayment | N/A | N/A | N/A | N/A | -12,880 |
| Common Stock Issued | 743,746 | 164,383 | 42,295 | 167,496 | 914 |
| Other Financing Activity | -235 | -388 | -344 | -401 | -2,721 |
| Financing Cash Flow | $743,511 | $163,995 | $41,951 | $167,095 | $134,393 |
| Exchange Rate Effect | 16 | -56 | 117 | -178 | -25 |
| Beginning Cash Position | 161,439 | 79,926 | 143,235 | 47,699 | 74,854 |
| End Cash Position | 524,747 | 161,439 | 79,926 | 143,235 | 47,699 |
| Net Cash Flow | $363,308 | $81,513 | $-63,309 | $95,536 | $-27,155 |
| Free Cash Flow | |||||
| Operating Cash Flow | -82,176 | -70,016 | -67,390 | -49,109 | -41,827 |
| Capital Expenditure | N/A | -42 | -52 | -275 | -340 |
| Free Cash Flow | -82,176 | -70,058 | -67,442 | -49,384 | -42,167 |